Venlafaxine is a unique antidepressant medication with well documented efficacy and safety in the acute treatment of major depressive disorder. Reports suggest that it may also be effective in the treatment of dysthymic disorder and bipolar II depression, but the available data for these conditions
Pharmacological principles of antidepressant efficacy
โ Scribed by Alan F. Schatzberg
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 68 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.399
No coin nor oath required. For personal study only.
โฆ Synopsis
Both noradrenaline (NA) and serotonin (5-HT) appear to be involved in depression. Evidence suggests that dual-acting antidepressants, i.e. those that affect both monoamine systems, such as tricyclic antidepressants and the noradrenergic and specific serotonergic antidepressant mirtazapine, may have greater efficacy and a faster onset of action than drugs that act on a single monoamine system only, such as the selective serotonin reuptake inhibitors (SSRIs). Cell firing is reduced by SSRIs in the short-term, but is increased by mirtazapine, probably due to its actions on both NA (via alpha(2) antagonism) and 5-HT (via alpha(1)-stimulation by NA). This may help to explain clinical evidence suggesting that mirtazapine has a faster onset of action than the more selective antidepressants.
๐ SIMILAR VOLUMES
The 1 -(2-hydroxy-1 -phenylethyl)-imidazole derivative Hoe 249 has a profile which suggests the compound is a promising candidate for clinical evaluation as an antidepressant drug. In pharmacological tests commonly considered predictive of antidepressant activity, e.g., reserpine-and tetrabenazine-a